
World Health Organization
UN health agency; sets global outbreak norms, declared first Bundibugyo PHEIC 17 May 2026.
Last refreshed: 14 July 2026 · Appears in 2 active topics
With 534 confirmed cases and no approved Bundibugyo countermeasure, can WHO translate science into guidance fast enough?
Timeline for World Health Organization
Reported the 44% isolation rate on 3 July
Pandemics and Biosecurity: Isolation slips as Ebola funding arrivesPABS talks reopen under a deadline
Pandemics and BiosecurityPublished DON612 putting confirmed cases at 1,481
Pandemics and Biosecurity: Ebola cases pass 1,481 as isolation lagsAnnounced the first patient enrolled in the Bundibugyo treatment trial
Pandemics and Biosecurity: Ebola trial doses its first patientAdded the first BDBV molecular diagnostic to its Emergency Use Listing
Pandemics and Biosecurity: WHO lists first Bundibugyo Ebola testWhy did WHO publish a fungal disease Blueprint in 2026?
What is WHO's fungal disease Blueprint?
How many Ebola cases has WHO's DON612 confirmed?
Background
The World Health Organization is a United Nations specialised agency founded in 1948, headquartered in Geneva, Switzerland. It coordinates international responses to disease outbreaks, health emergencies, and humanitarian crises, operating through six regional offices and a global logistics network that supplies medical goods to active disaster responses on every continent.
On pandemics and biosecurity, WHO is the central norm-setter and early-warning authority. On 17 May 2026, Director-General Tedros Adhanom Ghebreyesus declared the Bundibugyo ebolavirus outbreak in DRC and Uganda a PHEIC (the first Bundibugyo PHEIC in history and Tedros's fourth overall). The declaration carried a structural anomaly: no IHR Emergency Committee was convened and no Temporary Recommendations were issued. The technical assessment explicitly states the outbreak does not meet the new Pandemic Emergency tier criteria under the 2024 IHR amendments . The PHEIC arrived 24 hours after Africa CDC's continental emergency, repeating the institutional sequencing of the 2024 mpox Clade I episode.
By 8 June 2026, WHO DON606 recalibrated the outbreak count after clearing a testing backlog: the prior headline figure of approximately 1,000 cases was cut to 116 suspected cases, with reporting shifting to confirmed-only; confirmed cases stand at 534 with 93 deaths, a case-fatality ratio of 17.4% . DRC confirmed cases rose from 321 to 515 in five days. WHO advisory groups continue to assess MBP134 and remdesivir without having authorised either; the Ervebo vaccine and Inmazeb and Ebanga monoclonals all target Zaire ebolavirus only. Maria Van Kerkhove has publicly qualified vaccine deployment as conditional on strain compatibility .
Prior to the Bundibugyo outbreak, WHO's credibility turned on the speed at which it translates emerging Science into guidance. Its Disease Outbreak News 599 on the MV Hondius hantavirus cluster framed risk as rodent-only before a Swiss returnee confirmed Andes-strain person-to-person transmission, exposing how quickly DON assessments can be overtaken by laboratory results. The R&D Blueprint Filovirus roadmap published in Q1 2026 named non-Zaire Ebola species as a research-priority gap three months before this outbreak. H5N1 aerosol evidence from Emory University has not yet prompted WHO or PAHO to update dairy-worker PPE guidance.
By 2 July 2026, WHO delivered two long-absent tools within 48 hours: dosing the first patient in the Bundibugyo treatment trial in Ituri Province and adding the first molecular diagnostic for Bundibugyo virus to its Emergency Use Listing, lifting testing capacity from roughly 200-400 to more than 2,000 tests a day across ten laboratories . DON612, published 3 July, put the outbreak at 1,481 confirmed cases and 454 deaths, with patient isolation still near 44 percent against the 70 percent threshold the CDC model treats as the collapse point . WHO opened the seventh Intergovernmental Working Group session on the Pandemic Agreement in Geneva on 6 July, reopening the deadlocked PABS annex under a 17 July Deadline that Director-General Tedros and Brazilian President Lula jointly set in a 15 June open letter .
On 1 July 2026, WHO published its first-ever fungal disease and antifungal-resistance Blueprint, naming a research and surveillance gap that its bacteria-focused Global Action Plan on AMR had not addressed; the Blueprint sits alongside WHO's GLASS surveillance system, which tracks bacterial resistance only, giving WHO for the first time a named framework for the fungal blind spot. WHO's AFRO office continues to coordinate the Bundibugyo response as healthcare-worker infections mount, Africa CDC's 11 July appeal recording 112 responders infected and 35 dead.
Since the Iran conflict began on 28 February 2026, WHO has documented 13 verified attacks on healthcare facilities across Iran and Lebanon, killing 4 and injuring 25 . Director-General Tedros announced the Dubai emergency logistics hub was suspended due to conflict insecurity , stranding $26 million in humanitarian medical supplies and blocking orders serving 75 countries . The hub's suspension exposed a structural vulnerability: a regional war can sever supply lines relied upon by crisis-affected populations FAR beyond the conflict zone.